Drug rechanneling: A novel paradigm for cancer treatment
Itishree Kaushik et al, 2021, Seminars in Cancer Biology CrossRef
HPV-induced cancers: preclinical therapeutic advancements
Lorenzo Messa et al, 2022, Expert Opinion on Investigational Drugs CrossRef
HIV-1 Protease Inhibitors Slow HPV16-Driven Cell Proliferation through Targeted Depletion of Viral E6 and E7 Oncoproteins
Soyeong Park et al, 2021, Cancers CrossRef
Repurposing Alone and in Combination of the Antiviral Saquinavir with 5-Fluorouracil in Prostate and Lung Cancer Cells
Mariana Pereira et al, 2022, International Journal of Molecular Sciences CrossRef
Synergistic combination of ritonavir and cisplatin as an efficacious therapy in human cervical cancer cells: a computational drug discovery andin vitroinsight
Dayanand Swami et al, 2023, Journal of Biomolecular Structure and Dynamics CrossRef
Temporal trends in the epidemiology of cervical cancer in South Africa (1994–2012)
Gbenga Olorunfemi et al, 2018, International Journal of Cancer CrossRef
Identification of therapeutically potential targets and their ligands for the treatment of OSCC
Pratima Kumari et al, 2022, Frontiers in Oncology CrossRef
SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion
Zheng Yao Low et al, 2022, Viruses CrossRef
The immuno-oncological challenge of COVID-19
Lisa Derosa et al, 2020, Nature Cancer CrossRef
Molecular Mechanisms of HIV Protease Inhibitors Against HPV-Associated Cervical Cancer: Restoration of TP53 Tumour Suppressor Activities
Lilian Makgoo et al, 2022, Frontiers in Molecular Biosciences CrossRef
Senescence as a main mechanism of Ritonavir and Ritonavir‐NO action against melanoma
Svetlana Paskaš et al, 2019, Molecular Carcinogenesis CrossRef
Defining Diffuse Large B-Cell Lymphoma Immunotypes by CD8+ T Cells and Natural Killer Cells
Jing Qi et al, 2022, Journal of Oncology CrossRef
Saquinavir: From HIV to COVID-19 and Cancer Treatment
Mariana Pereira et al, 2022, Biomolecules CrossRef